1-hydropyrrolizine derivatives and their synthetic methods and applications
A synthetic method and compound technology, which is applied in the field of medicine, can solve the problems of complex experimental operation conditions, long steps, and low compatibility between substrates and functional groups, and achieve good anti-tumor activity, short cycle time, and simple and easy-to-control synthetic methods.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] The 1-hydropyrrolazine derivatives of the present invention are synthesized according to the following synthetic route.
[0051]
[0052] 3aa:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R 5 =CO 2 Et, R 6 =CO 2 Et;
[0053] 3ba:R 1 = 4-MeOC 6 h 4 , R 2 = 4-MeOC 6 h 4 , R 3 = Me,R 4 = Me,R 5 =CO 2 Et, R 6 =CO 2 Et;
[0054] 3ca:R 1 = 4-CF 3 C 6 h 4 , R 2 = 4-CF 3 C 6 h 4 , R 3 = Me,R 4 = Me,R 5 =CO 2 Et, R 6 =CO 2 Et;
[0055] 3da:R 1 =3-BrC 6 h 4 , R 2 = 4-BrC 6 h 4 , R 3 = Me,R 4 = Me,R 5 =CO 2 Et, R 6 =CO 2 Et;
[0056] 3ea:R 1 = Ph, R 2 = Ph, R 3 = H, R 4 = Ph, R 5 =CO 2 Et, R 6 =CO 2 Et;
[0057] 3fa:R 1 = Ph, R 2 = Ph, R 3 =Et,R 4 =Et,R 5 =CO 2 Et, R 6 =CO 2 Et;
[0058] 3ga:R 1 = Ph, R 2 = Ph, R 3 , R 4 =(CH 2 ) 4 , R 5 =CO 2 Et, R 6 =CO 2 Et;
[0059] 3ab:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R 5 =CO 2 n Bu, R 6 =CO 2 n Bu;
[0060] 3ac:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R ...
Embodiment 2
[0090] The 1-hydropyrrolazine derivatives of the present invention are synthesized according to the following synthetic route.
[0091]
[0092] 3ag:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R 5 = H, R 6 =COCH 3 ;
[0093] 3ah:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R 5 = Ph, R 6 = CN;
[0094] 3ai:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R 5 = H, R 6 =CONMe(OMe);
[0095] 3aj:R 1 = Ph, R 2 = Ph, R 3 = Me,R 4 = Me,R 5 = Ph, R 6 = 4-MeC 6 h 4 SO 2 .
[0096] N-alkenyl α, β-unsaturated nitrone substrate 1 (0.3mmol), alkyne reagent 2 (0.6mmol), catalyst (target 3ag-3aj catalysts were ferric acetate, copper chloride, trifluoro Copper methanesulfonate and cuprous bromide) (0.03mmol) are placed in reaction tube, add 3mL organic solvent (the organic solvent that target object 3ag-3aj adopts is respectively benzene, cyclohexane, ether, composed of dioxane and Hexane mixed at a volume ratio of 1:2), stirred and reacted at 40°C for 3 to 15 hours, the obtained re...
experiment example 1
[0105] Experimental Example 1: The 1-hydropyrrolazine derivatives of the present invention were tested for their inhibitory activity against various human tumor strains in vitro:
[0106] (1) Cell culture: MGC-803, HepG-2, NCI-H460, SKOV3, T24, 7702 cells were cultured in a medium containing 10% (volume ratio) fetal bovine serum and 1% (volume ratio) double antibody (containing penicillin and Streptomycin) in DMEM medium at 37°C, 5% CO 2 and 95% air incubator, and change the medium every other day. After the cells were confluent, they were passaged and frozen.
[0107](2) Seed plate: Take the cells in the logarithmic growth phase, remove the old medium, wash twice with PBS, digest the cells with trypsin, add new medium after the cells become round, stop the digestion of the cells and pipette the suspended cells to prepare into a single cell suspension. Take an appropriate amount of cell suspension, add a certain amount of medium to dilute, inoculate into a 96-well plate, 18...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


